Skip to main content
OpenTrials
Completed

NCT Number: NCT00535106

SmartCPR Trial: An Analysis of a Waveform-Based Automated External Defibrillation (AED) Algorithm on Survival From Out-of-Hospital Ventricular Fibrillation

This study is designed to examine the impact of an available technology within an automated external defibrillator (AEDs) to improve survival following out-of-hospital cardiac arrest for patients presenting in ventricular fibrillation.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

London Ambulance Service, London, England, United Kingdom

Loading trial locations.

About this study

The delivery of an electrical shock, termed defibrillation, has long been recognized as one of the critical "links" in the "Chain of Survival" following out-of-hospital cardiac arrest. This is particularly the case for patients who present in ventricular fibrillation (VF), a state of constant and yet uncoordinate firing of the lower portions of the heart (the ventricles), and the ability to treat these patients with defibrillation prior to their arrival in the hospital has remained one of the reasons why this group represents the patients who are most likely to survive an out-of-hospital cardiac arrest.

Though this technology has been successfully utilized in the prehospital setting for more than forty years, the long-held belief that "immediate defibrillation" was the optimal treatment for all patients has now come into question.

Following research done in locations such as Seattle, WA and Oslo, Norway, there came a recognition that some patients (particularly those who have been in cardiac arrest for 4-5 minutes prior to EMS arrival) may actually benefit from a period of CPR prior to defibrillation ("delayed defibrillation"). This has to do with the changes that take place within the heart and even at the level of the cells within the heart following the onset of VF. After several minutes of VF, the cells within the heart have been deprived and depleted of oxygen and other energy-containing molecules, and there has been a build-up of other substances such as acids and potassium. By providing CPR prior to defibrillation, it is thought that the patient's heart may be provided with enough oxygen and other energy-containing molecules, making it more likely that the heart will respond favorably to defibrillation.

Yet this is not necessarily true for all VF patients. Other data from patients whose collapse and cardiac arrest were witnessed and for whom defibrillation was able to be provided quite rapidly (i.e. those in airports, airplanes, and casinos) demonstrate a very high survival rate when compared to those patients who have been in arrest for a longer period. This suggests that there are patients who are best treated with immediate defibrillation and those who are treated with "delayed defibrillation."

The problems for modern emergency medical services (EMS) systems include determining just when the VF began, the impact of bystander CPR, the patient's overall condition at the time of the cardiac arrest, and the time interval from the 911 call until the arrival of the EMS providers (EMTs and paramedics) at the side of the patient.

By choosing to provide immediate defibrillation to all patients, in hopes of benefiting those who are most likely to respond to defibrillation and to survive, an EMS system would simultaneously be choosing to provide less than ideal treatment to those patients who are likely to benefit from "delayed defibrillation." Conversely, choosing to provide "delayed defibrillation" to all patients likely treats the larger percentage of VF patients in any EMS system appropriately, yet it potentially delays life-saving treatment from those who are most likely to survive (the patients who would benefit from immediate defibrillation).

Research involving the mathematic properties of the VF waveform (something that the human eye cannot calculate) have led to the development of computer algorithms that may predict, based on the calculated mathematical "score" of the VF, whether a patient is likely to respond more favorably to immediate defibrillation or delayed defibrillation. Such a technology could, therefore, seem to be able to recommend every patient to the treatment that is best for their individual condition, and it would follow that such individual treatment may improve survival from VF cardiac arrest overall.

This study is designed to examine the effect of just such a technology on VF patients presenting to EMS providers in New York, NY and London, England.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • initial treatment includes application of a study AED
  • complete initial waveform analysis
  • presenting rhythm is ventricular fibrillation
  • arrest of cardiac etiology

Exclusion criteria

  • arrest of noncardiac etiology
  • initial treatment with a non-study defibrillator
  • missing AED data
  • age <18 (London only)
  • resuscitation terminated due to a DNR order / decision

Treatment and study plan

Automated external defibrillator (Philips FR2+ AED)

Device

Patients in this arm will be provided with immediate defibrillatory shock coupled with otherwise standard resuscitative efforts.

Other names: Philips FR2+ AED

SmartCPR

Device

Patient in this arm will be treated with standard resuscitation efforts except that the first AED analysis will utilize an waveform-based algorithm to recommend either immediate defibrillation or delayed defibrillation for each patient.

Delayed defibrillation

Other

In New York City only, all patients not initially treated by study personnel will receive other regional standard for resuscitation - delayed defibrillation.

Primary outcomes

  1. Survival to Hospital Discharge

    Time frame: Variable (depends upon interval needed for hospital admission and discharge)

Secondary outcomes

  1. Survival to hospital admission

    Time frame: within hours from the time of arrest

  2. Return of spontaneous circulation (ROSC) in prehospital setting

    Time frame: Variable (depends on EMS contact time)

  3. Neurological status among survivors

    Time frame: Variable (measured at hospital discharge)

  4. Survival (defined as ROSC, survival to hospital admission, and survival to hospital discharge) as compared to a "delayed defibrillation" cohort in NYC

    Time frame: Variable (depends upon interval needed for hospital admission and discharge)

  5. Impact of CPR interval on VF waveform characteristics

    Time frame: Immediately after CPR interval

  6. Utility of AED algorithm and VF characteristics among EMS-witnessed arrests

    Time frame: Variable (some immediate data, some depends upon interval needed for hospital admission and discharge)

  7. Utility of this AED technology and VF characteristics among pediatric patients

    Time frame: Variable (some immediate data, some depends upon interval needed for hospital admission and discharge)

  8. Impact of bystander CPR on VF waveform characteristics

    Time frame: Immediate (taken from data during arrest)

  9. Comparison of EMS response times to VF waveform characteristics

    Time frame: Immediate (data obtained during EMS response and arrest period)

  10. Frequency of unmanageable airways in out-of-hospital cardiac arrest patients

    Time frame: Immediate (measured at the time of arrest)

  11. Impact of patient race upon the provision of bystander CPR, VF waveform characteristics, and survival

    Time frame: Variable (depends upon interval needed for hospital admission and discharge)

  12. Relationship between presenting and interval waveform capnography readings and survival

    Time frame: Variable (depends upon interval needed for hospital admission and discharge)

  13. Frequency of organ donation among out-of-hospital cardiac arrest patients transported to the hospital who do not survive to hospital discharge

    Time frame: Variable (depends upon interval needed for hospital admission and discharge)

  14. Waveform characteristics among patients presenting in secondary VF (initial presenting rhythm asystole or pulseless electrical activity)

    Time frame: Immediate (derived from data collected during the arrest)

  15. Description of and outcomes of patients for whom intraosseous access is utilized during the cardiac arrest

    Time frame: Variable (depends upon interval needed for hospital admission and discharge)

  16. Utstein comparison of two cities (London and New York)

    Time frame: Variable (depends upon interval needed for hospital admission and discharge)

  17. Impact of bystander CPR on survival as a function of response time

    Time frame: Variable (depends upon interval needed for hospital admission and discharge)

  18. Association between ambient small particle (PM2.5) pollution and cardiac arrest indicence in New York City

    Time frame: To be determined by modelling

Sponsors and collaborators

Lead sponsor

New York City Fire Department

Other Gov

Collaborators

  • London Ambulance Service
  • Philips Medical Systems

Registry information

Official study title

An International, Randomized, Controlled Prehospital Trial of a Waveform-Based Automated External Defibrillation Algorithm for the Management of Ventricular Fibrillation

Acronym: SmartCPR

Important dates

Study start
2006
Primary completion
2009
Study completion
2009
First posted
Sep 26, 2007
Registry last updated
Oct 19, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.